Skip to content

Clinical trials

Completed Alzheimer Disease trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Status: Completed Country / region: Japan Clear all

60 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20063
20074
20088
20095
20103
20112
20128
20135
20143
20155
20163
20172
20181
20202
20212
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed60

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company14
Eisai Co., Ltd.6
Pfizer6
Wyeth is now a wholly owned subsidiary of Pfizer6
Janssen Pharmaceutical K.K.4
Novartis Pharmaceuticals4
Avid Radiopharmaceuticals2
Eisai Inc.2
Kyowa Kirin Co., Ltd.2
Lantheus Biosciences Ltd.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease60
Dementia9
Cognitive Dysfunction8
Tauopathies4
Plaque, Amyloid3
Amyloid Neuropathies, Familial2
Amyloidosis2
Brain Diseases2
Central Nervous System Diseases2
Delirium2

Trials

Showing 1 to 25 of 60. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.